Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009
The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 268s Year: 2001
Theophylline drip infusion reduces peripheral blood eosinophil counts and ECP (eosinophil cationic protein) level on acute exacerbation of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002
Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels Source: Eur Respir J 2004; 23: 759-762 Year: 2004
Circadian variations in serum eosinophil cationic protein (ECP), and serum and urine eosinophil protein X (EPX) in children Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001
Mycoplasma pneumoniae infection affects total eosinophil count, the serum level of ECP, and interleukin-5 in atopic childrenSource: Annual Congress 2012 - Airway infections in children: from risk factors to treatment Year: 2012
High sensitivity C-reactive protein in asthma Source: Eur Respir J 2006; 27: 908-912 Year: 2006
Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients? Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001
Serum concentration of C-reactive protein is not a good marker of bronchial hyperreactivity Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Inflammatory-cellular composition of the induced sputum (IS) and activity of leucocytes myeloperoxidase (MPO) in asthmatics with different airway response to hyperosmolar stimulus Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016
Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children Source: Eur Respir J 2002; 20: Suppl. 38, 114s Year: 2002
Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Correlation of high eosinophilic cathionic protein (ECP) levels with allergy parameters Source: Eur Respir J 2003; 22: Suppl. 45, 292s Year: 2003
High-sensitive C-reactive protein is associated with reduced lung function in young adults Source: Eur Respir J 2009; 33: 382-388 Year: 2009
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019